Status:
COMPLETED
Understanding the Mechanisms of Critical Illness Myopathy by Use of a Novel Electrophysiological Method - MVRCs
Lead Sponsor:
Sándor Beniczky
Collaborating Sponsors:
Danish Council for Independent Research
University of Aarhus
Conditions:
Critical Illness Myopathy
Myopathy Critical Illness
Eligibility:
All Genders
18+ years
Brief Summary
Critical illness myopathy (CIM) is a disabling condition that develops in critically ill patients. The syndrome is not only a cause of prolonged intensive care hospitalisation but also a main reason f...
Eligibility Criteria
Inclusion
- Patients: Fulfilled sepsis criteria of an increase in the Sequential (Sepsisrelated) Organ Failure Assessment (SOFA) score of 2 points or more.
Exclusion
- Patients and controls:
- Earlier peripheral nervous system disease
- History of malignancy, diabetes mellitus, alcoholism, medicine or other causes of polyneuropathy or myopathy
- Bleeding tendency or anticoagulation therapy
Key Trial Info
Start Date :
January 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2024
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04711070
Start Date
January 4 2021
End Date
February 1 2024
Last Update
February 2 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anaesthesiology and Intensive Care, Aarhus University Hospital
Aarhus C, Denmark, 8000
2
Department of Clinical Neurophysiology, Aarhus University Hospital
Aarhus C, Denmark, 8000